INVUITY, INC.
SAN FRANCISCO, CA

Invuity, Inc., founded on January 28, 2018, and registered in Florida, is a pioneering medical technology company headquartered in San Francisco, CA, with a mailing address at 444 De Haro Street. Specializing in intelligent photonics, Invuity advances surgical procedures by enhancing direct visualization within minimal access surgeries. The firm's proprietary Intelligent Photonics technology provides superior illumination that surpasses traditional operating room lighting solutions, focusing on intraoperative efficiency and safety. Invuity targets a comprehensive product portfolio for use across a range of minimally invasive operations, promising significant clinical and economic benefits. Under the leadership of key figures such as Joe Guido, Vice President of Commercial Marketing & Business Development since April 2016, and Steve Annen, VP of Product Management and Strategy, the company leverages strategic insights to drive growth and innovation. Gregory T. Lucier from NuVasive complements its board with profound industry expertise. The innovative technology integrates modified optical waveguides with standard operating equipment such as xenon and LED sources, ensuring an evenly illuminated surgical field. Invuity’s public offering activities have been noteworthy; specifically, the company publicly offered 6,200,000 shares priced at $3.50 on March 15, 2018, alongside subsequent management adjustments. Committed to advancing medical technology, Invuity continuously invests in its commercial strategies and technologies to maintain leadership within the field of minimally invasive surgery. The company remains publicly traded under NASDAQ: IVTY with its most recent annual report filed on March 20, 2024.